HIV Clinical Trial
Official title:
Body Image in Youth With HIV
This is an observational study that seeks to gather information about perceptions of body
image through the use of a one-time questionnaire completed by participants at the time of
study enrollment.
Effective management of Human Acquired Immune Deficiency Syndrome (AIDS) caused by the Human
Immunodeficiency Virus (HIV) has become possible through the use of Highly Active
Antiretroviral Treatment (HAART). As a result of more successful treatment options, HIV/AIDS
has transitioned from a terminal illness to one which is treated as a chronic condition. One
particular group that has been impacted tremendously by HIV in the United States is the
adolescent population. As youth are living longer with HIV/AIDS, clinicians and researchers
are beginning to examine ways in which the disease can affect one's physical health, mental
health, and other psychosocial factors. Research emerging involving adults with HIV/AIDS has
suggested that increased attention to and negative views of one's body image may be found at
a higher rate in this group. To our knowledge, very few studies have examined this
relationship in adolescents with HIV.
The purpose of this exploratory study is to characterize body image perceptions among youth
with perinatally and behaviorally acquired HIV. In a cross-sectional design, adolescents
will be asked to complete an ACASI questionnaire that will assess body image, medication
adherence, depressive symptoms, medical, and other sociodemographic variables which may
relate to adolescents with HIV. Information regarding the adolescents' medical history,
medications, and physical functioning also will be abstracted from his or her medical
record. Guided by the Intervention Mapping (IM) approach, findings from this study will
inform future intervention studies designed to enhance HIV disease management among
adolescents.
PRIMARY OBJECTIVE:
To characterize body image perceptions among youth with HIV.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |